Model‐based Meta‐Analysis on the Efficacy of Pharmacological Treatments for Idiopathic Pulmonary Fibrosis

Recently, the US Food and Drug Administration (FDA) approved the first two drugs (pirfenidone and nintedanib) indicated for the treatment of idiopathic pulmonary fibrosis (IPF). The purpose of this analysis was to leverage publicly available data to quantify comparative efficacy of compounds that ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Phyllis, Bax, Leon, Chen, Chunlin, Zhang, Nancy, Huang, Shu‐Pang, Soares, Holly, Rosen, Glenn, AbuTarif, Malaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658284/
https://www.ncbi.nlm.nih.gov/pubmed/28699195
http://dx.doi.org/10.1002/psp4.12227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658284/
https://www.ncbi.nlm.nih.gov/pubmed/28699195
http://dx.doi.org/10.1002/psp4.12227

Ejemplares similares